Abstract
Introduction
Achalasia cardia is a motility disorder, primarily characterized by abnormal or absent relaxation of the lower oesophageal sphincter (LOS). More speci cally, it is a neuromuscular disorder characterized by degenerative changes of the myenteric plexus leading to a selective loss of inhibitory nerve endings. Irreversible disruption of peristaltic contractions and impaired relaxation of the lower esophageal sphincter in response to deglutition are the consequences of this damage. 1 is condition, regardless of its cause, ultimately results in abnormal transit of oesophageal contents from the distal oesophagus into the stomach and progressive oesophageal dilatation.
Primary idiopathic achalasia cardia is a quite rare disease, with an incidence of approximately 1/100,000/year and a prevalence rate of 10/100,000. 2 Primary achalasia cardia in children is part of the Allgrove's and Alport's syndromes, and is more frequent in Down's syndrome. 2 Secondary achalasia cardia shares clinical features with primary achalasia cardia, but there is always an identi able cause. 3, 4 From the clinical point of view, achalasia cardia is a progressive disease that presents with symptoms of dysphagia both for liquid and solid foods, chest pain and regurgitation of undigested foods that occurs during meals, shortly thereafter or hours later when the patient changes into the recumbent position. Aspiration of food from the oesophagus may lead to pneumonia. Loss of weight and malnutrition are uncommon, but they may occur in advanced disease and in elderly patients. 5 Restoration of muscular activity and reversal of oesphageal aperistalsis is rarely reversed by any mode of treatment.
erefore, every treatment for achalasia cardia is directed at reducing the gradient across the lower oesphageal sphincter (LOS) with three goals: 1) relieving patient's symptoms, especially dysphagia and regurgitation, 2) improving oesophageal emptying and 3) reducing associated complications.
In the modern era of achalasia cardia treatment, disruption of LOS is best accomplished by pneumatic dilatation using the Pneumatic balloon dilator or laparoscopic myotomy. It is less e ectively treated with pharmacological agents, such as botulinum toxin injection or calcium channel blockers. Symptom of dysphagia and regurgitation are easier to treat, but chest pain relief is more unpredictable. 6 Overall, using single or multiple modalities of treatment, over 90% of patients remain well. 7 Pneumatic dilatation aims at disrupting the LOS by forceful stretching using air-lled balloons. In an updated review through 2009 of 1144 patients across 24 studies with an average follow up of 37 months, pneumatic dilatation using rigi ex balloon in a graded fashion gave good to excellent symptom relief in 74%, 86% and 90% treated with the 3.0, 3.5 and 4.0 cm balloon, respectively. 3,8 Over a third of treated patients experienced symptom relapse over 4-6 years of follow-up. 9-11 e risk factors for relapse after pneumatic dilatation are mainly young age (< 40 years), male gender, single dilatation with a 3.0 cm balloon, post-treatment LOS pressure >10-15 mm Hg and poor oesophageal emptying on an upright barium oesophagram (timed barium swallow). 6, 9, 12, 13, 14 Pneumatic dilatation is the most cost-e ective treatment for achalasia cardia over a time period of 5 to 10 years. 15, 16 e only absolute contraindication to pneumatic dilatation is poor cardiopulmonary status, or other co-morbid illnesses preventing surgery. Complications after pneumatic dilation are reported in up to 33% of patients with most complications being minor. 3 Oesophageal perforation is the most serious complication after pneumatic dilatation with an overall rate in experienced hands of 1.9% (range 0-16%). Most perforations occur during the rst dilatation, with di culty in keeping the balloon in position during the procedure as potential risk factor. 17 Severe complications i.e. GORD are rare after pneumatic dilatation, but 15-35% of patients have heartburn responding to proton pump inhibitors. 3 Other usually minor complications after pneumatic dilatation include chest pain, aspiration pneumonia, bleeding usually without a decrease in haemoglobin, transient fever, oesophageal mucosal tear without perforation and oesophageal haematoma.
e prognosis of patients su ering from achalasia cardia regarding returning to near-normal swallowing and good quality of life following pneumatic dilatation are excellentwith a single session of dilatation, though intermittent "touch up" procedures may be required. But 77 there is paucity of study conducted in the context of our population. Only one study was conducted in Bangladesh on 17 patients of achalasia reporting clinical presentation and outcome of management. 18 So the proposed study, intended to nd the outcome of pneumatic dilatation in patients with achalsia cardia seems to be justi ed. e data derived from the proposed study would be helpful to develop a comprehensive understanding about the life of the patients after the treatment and also helpful to guide the physicians in taking decisions about treatment of choice from the various treatment options for the management of achalasia cardia in our population.
Methods
is quasi-experimental study was carried out from January 2010 to December 2011 involving 31 patients of Achalasia Cardia admitted in the Department of Gastroenterology of BSMMU, Dhaka. Patients attending in the Department of Gastroenterology of BSMMU with the classical symptoms of achalasia cardia who underwent pneumatic dilatation were initially included in the study, based on prede ned enrollment criteria. After proper explanation written informed consent were obtained from the selected patients for upper GI endoscopy and pneumatic balloon dilatation. Selected patients underwent the procedure in the Department of Gastroenterology, BSMMU using an Olympus forward viewing video endoscope and Rigi ex balloon dilator. During the procedure aseptic precaution were adopted and the same technique were followed and maintained for each patient.
Overall post-procedure observation period was 4-6 hrs to exclude perforation and evaluate for chest pain and fever. After 6 hrs of observation, patients were allowed to drink uids. Patients with pain during this observation period were checked for any complications. If no complication, patients were discharged home next day with instructions to attend the follow up clinic 2 -4 weeks thereafter. In the follow up clinic, symptoms and oesophageal function, specially oesophageal emptying were assessed. A barium swallow X-ray of oesophagus and/or endoscopy was performed in case of any suspicion of complication.
Data were processed and analyzed using SPSS (Statistical Package for Social Sciences) version 11.5. Test statistics used to analyses the data were descriptive statistics, McNemar Chi-square (χ 2 ) and Willcoxon Signed Rank Test. e level of signi cance for any analytical tests was set at 0.05 and p <0.05 was considered signi cant.
Results
Demographic characteristics of the patients show that 16.1% of the patients were < 20 years old, 22.6% 22 -30 years, 22.6% 30 -40 years, 29% 40 -50 years and 9.7% ≥50 years old. e mean age of the patients was 34 years and youngest and oldest patients were 8 and 70 years old respectively. Male female ratio was almost 1:1.
Distribution of patients by their body mass index demonstrates that over half (51.6%) of the patients was underweight (BMI < 18.5 kg/m2) (Figure-1) .
Mode of clinical presentation shows that dysphagia for solids or liquids and regurgitation of undigested food were invariably complained by the patients. Majority (96.8%) of the patients experienced weight loss followed by chest pain (87.1%), nocturnal cough and halitosis (each 67.7%), hiccup (38.7%) and symptoms of pneumonia (25.8%) ( Table-I On endoscopic examination 38.7% cases exhibited peristaltic movement. Over half (52%) of the patients contained small amount, 24% moderate amount and another 24% huge amount of food in the oesophagus. In 50% of the cases, the lower oesophageal sphincter was observed to be moderately constricted, in 25% cases severely constricted and in another 25% cases mildly constricted ( Table-II Barium swallow X-ray of oesophagus showed that 22.6% of the oesophagus was hugely dilated, 63.3% moderately dilated and 13.3% mildly dilated. About 42% patients exhibited bird-beak appearance and 58% narrowing of the lower end of oesophagus. Sixteen percent patients developed sigmoid-shaped oesophagus ( Table-III) . Severe oesophagus During pneumatic dilatation the median pressure in the balloon was 11.5 mm of water. e average time required to dilate the sphincter was 42.5 second, while the lowest and the highest time needed were 30 and 120 seconds respectively. Some patients required more than one sessions, and as such, the average number of sessions of pneumatic dilatation was 2 and the average years between the sessions was 5.
Table-III: Findings of barium swallow X-ray of oesophagus

Figure-1: Distribution of patients by the BMI
Immediate outcome of pneumatic dilatation shows that all the patients improved in terms of relief of dysphagia and discharged from hospital next day. In majority (96.4%) of the cases, mucosal tear was seen at endoscopy. 85% of the patients had minimal pain at the site of dilatation. However, 82.1% patients complained of chest pain. None of the patients complained of dysphagia or regurgitation of the undigested food ( Figure-2 ).
Majority (82.1%) of the cases developed chest pain following pneumatic dilatation and 10.7% had bleeding from the site of dilatation but bleeding was not severe enough necessitating blood transfusion (Figure-3) .
79
e evaluation of the outcome of pneumatic dilatation after 4 weeks. General condition of all patients improved except one, although about 70% had heartburn, 7.7% had chest pain, another 7.7% had oesophageal ulcer and 3.4% persisted dysphagia (Figure-4) . e weight of patients after 4 weeks of pneumatic dilatation increased signi cantly from their baseline status (45.5 ± 9.4 vs. 50.2 ± 9.0, p < 0.001). Comparing BMI before and after pneumatic dilatation also revealed that proportion of underweight patients reduced signi cantly from 57.7% before dilatation to 38.5% 4 weeks after dilatation (p = 0.036). (Table-IV) . Table- Discussion e present study intended to nd the outcome of pneumatic dilatation in patients of achalasia cardia and included a total of 31 patients. Of them 2 patients did not * * * p-value -< 0.001, ** p-value -0.036 ¶ Data were analysed using McNemar Chi-square Test.
# Data were analysed using Wilcoxon Signed Rank Test
Figures in the parentheses correspond percentages.
and presented as mean ± SD.
complete the treatment and 3 patients dropped following pneumatic dilatation. Over 60% of the patients were younger (< 40 years old) with a mean age of 34 years (range 8 -70 years) and male to female ratio roughly 1:1. More than 50% of the patients were underweight with respect to their BMI. Dysphagia for solids or liquids, bland regurgitation and weight loss were the universal complaints of the patients. Hiccup and symptoms of pneumonia were less commonly reported. Peristaltic movement of oesophagus was seen in 38% of the cases with moderate to huge content of undigested foods (48%) and moderate to severe constriction of LOS (75%). Barium swallows X-ray of oesophagus demonstrated moderate to hugely dilated oesophagus (86.7%) and either narrow (58.1%) or bird-beak (41.9%) appearance of lower end of oesophagus. Development of sigmoid oesophagus was substantially lower (16.1%).
Immediately after pneumatic dilatation all the patients got relief of dysphagia and were discharged from hospital next day. Mucosal tear was visible on endoscopic examination. Majority (96.2%) of patients at 4 weeks of evaluation experienced improved emptying of oesophagus, though heartburn and dysphagia were complained by 70% and 11.5% cases respectively. Four weeks after pneumatic dilatation, number underweight patients reduced to 38.5% from 57.7% at baseline. About 52% of the patients required 1 dilatation, 25.9% 2 dilatations and 22% 3 dilatations.
Ghoshal and associates conducted a retrospective study on 126 patients of achalasia cardia (mean age 36.5 ± 14.6 yrs, 76 male) to nd the factors associated with nonresponse and recurrence after pneumatic dilatation (PD). 13 Symptoms were dysphagia (100%), chest pain (17%), regurgitation (48%), weight loss (26%), and pulmonary symptoms (18%); 5 of 126 (4%) had megaesophagus. e mean lower oesophageal sphincter (LOS) pressure was 38.7 ± 16.8 mmHg. Over 90% of patients responded to PD (71% to rst session); 25 of these had recurrence of dysphagia after a median period 15 months. Post-PD chest pain requiring hospitalization occurred in 17%. Post-PD LOS pressure, which was assessed in 48 of 126 patients, had decreased by > 50% from baseline in 14 of 29 responders, none of 11 nonresponders and 5 of 8 relapsers. e median dysphagia-free duration was 60 months (95% CI = 54.7 -65.3). In our study we did not measure lower oesophageal sphincter pressure. However, with respect to symptom relief and number of sessions required, the ndings of the present study is quite consistent with those of Ghoshal et al (2004) . 13 In an updated review through 2009 of 1144 patients across 24 studies with an average follow up of 37 months, Rigi ex pneumatic dilatation in a graded fashion gave good to excellent symptom relief in 74%, 86% and 90% treated with the 3.0, 3.5 and 4.0 cm balloon, respectively (Richer, 2008) . Over a third of treated patients experienced symptom relapse after 4-6 years of follow-up. 9 e risk factors for relapse after pneumatic dilatation are mainly young age (<40 years), male gender, single dilatation with a 3.0 cm balloon, post-treatment LOS pressure >10-15 mm Hg and poor esophageal emptying on an upright barium oesophagram (timed barium swallow). 6, 9, 12, 13, 14 Pneumatic dilatation is the most cost-e ective treatment for achalasia cardia over a time period of 5 to 10 years. 15, 16 Complications after pneumatic dilatation are reported in up to 33% of patients with most complications beingminor. In the present study as well we observed 82% patients to develop chest pain as immediate complications. Only 10% patients have had gastrointestinal bleeding but the bleeding was not too severe to require blood tranfusion. However, Ghoshal (2004) reported a somewhat higher incidence of post PD chest pain (17%) requiring hospitalization (one of them had an esophageal perforation). 13 ere was no incidence of perforation after pneumatic dilatation. Severe complications like GORD are rare after pneumatic dilatation, but 15-35% of patients have heartburn responding to proton pump inhibitors.8 In our series patients who complained of heartburn 4 weeks after PD, 1 (3.4%) of them exhibited oesophageal ulcer on endoscopic examination. e patient responded well to proton pump inhibitors bearing consistency with ndings of. 8
From the ndings of the present study and discussion thereof it can be concluded that all the patients following pneumatic dilatation relieved of obstruction in the lower oesophageal sphincter and improved emptying of oesophageal contents with relieved of dysphagia without major complications. Patients discharged from hospital next day and return to their usual work. Majority of the patients at 4 weeks follow up show improvement in oesophageal emptying, although some minor symptoms like heartburn and chestpain are complained. Pneumatic dilatation is a simple, safe and e ective method for treating patients with achalasia cardia in Bangladeshi population.
